The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The Lupus Initiative Receives 5-Year CDC Grant

The Lupus Initiative Receives 5-Year CDC Grant

October 28, 2015 • By American College of Rheumatology

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The Centers for Disease Control and Prevention (CDC) has awarded the American College of Rheumatology’s (ACR) The Lupus Initiative (TLI) with a five-year grant to support the development of a national, grassroots program targeting primary care providers, persons with undiagnosed Lupus and rheumatology health care providers. The program will have three components:

You Might Also Like
  • The Lupus Initiative Launches Cohorts & Partnerships to Reduce Health Disparities & Improve Outcomes
  • The ACR’s Lupus Initiative Expands Training, Educational Resources
  • ACR’s Lupus Initiative Advances Education Around Diagnosing, Treating Disease
Also By This Author
  • ACR’s New AS & Nonradiographic Axial SpA Treatment Recommendations
  • Immediate dissemination of educational and training materials currently available on Lupus to state and local organizations throughout the country,
  • Development of a general awareness campaign to help the public identify signs and symptoms of Lupus and seek medical care, and
  • Development of community-tailored activities that will be piloted in select communities during the first year of the initiative.

“Not only is Lupus often misdiagnosed, but patients commonly see at least three providers before diagnosis, many of whom are primary and emergency care providers who haven’t received significant training in diagnosing Lupus,” said Sheryl McCalla, TLI Project Director and ACR Senior Director, Collaborative Initiatives. “These providers may have received an average of 90 minutes of training on Lupus in the first and second years of medical school combined. This often contributes to delays in timely and accurate diagnosis, both of which are critical to helping patients manage and live with this condition. We are hoping to change that by educating both the public and providers on what to look for and the best steps to take when they suspect Lupus.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Lupus is an autoimmune disease in which the immune system produces antibodies to cells within a person’s own body, leading to widespread inflammation and tissue damage. While the disorder can occur within any gender or ethnicity, women are affected eight times more often than men, and people of color are affected in higher numbers than whites, especially African Americans, Hispanics/Latinos and American Indian/Alaska Native populations. Additionally, women are often affected between age 15–40 during their prime years for education, career advancement and childbearing. And people of color with Lupus are more likely to suffer from comorbidities such as depression, cardiovascular disease and diabetes in additional to high prevalence and mortality rates.

The first phase of the program is scheduled to start in November and will focus on the national dissemination of TLI’s existing evidence-based education materials and programming. Foundational work for the next phases, community activities to pilot and an awareness campaign, are slated to begin in early 2016. The ACR plans to collaborate with the Lupus Foundation of America—who was also awarded grant funding—on the development of the awareness campaign.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 | Single Page

Filed Under: Conditions, From the College, SLE (Lupus)

You Might Also Like:
  • The Lupus Initiative Launches Cohorts & Partnerships to Reduce Health Disparities & Improve Outcomes
  • The ACR’s Lupus Initiative Expands Training, Educational Resources
  • ACR’s Lupus Initiative Advances Education Around Diagnosing, Treating Disease
  • The ACR’s Collaborative Initiatives Promote Awareness of Lupus, Rheumatic Diseases

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.